Product Information
AMLODIPINE-OLMESARTAN 10-40 MG is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.3161 per EA under NDC 27241008609. Its NADAC has been published 501 times since Jan 18, 2017.
FDA first approved this application on Oct 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 40 mg/1; mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241008609
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207216FDA Approved
10/28/2016
TE Code
AB
On Market Since
2/6/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has been published 501 times since Jan 18, 2017, and over the history we have for it it has declined 69.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3161 per EA |
|---|---|
| All-time high | $1.1664 (Mar 15, 2017) |
| All-time low | $0.2641 (Jan 17, 2024) |
| 52-week high | $0.3755 |
| 52-week low | $0.3156 |
| Median price | $0.5022 |
| Average price | $0.5824 |
| Largest weekly change | +47.0% (Nov 22, 2023) |
| Weeks tracked | 501 |
| Tracking since | Jan 18, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 10-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-40 MG, manufactured by Ajanta Pharma USA Inc., is $0.3161 per EA (NDC 27241008609), effective Aug 19, 2026.
How has the price of AMLODIPINE-OLMESARTAN 10-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has declined 69.5%. It has been tracked across 501 weekly CMS publications since Jan 18, 2017.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-40 MG?
Since Jan 18, 2017, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has ranged from a low of $0.2641 (Jan 17, 2024) to a high of $1.1664 (Mar 15, 2017), with a median of $0.5022 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-40 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-40 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 10-40 MG?
AMLODIPINE-OLMESARTAN 10-40 MG (NDC 27241008609) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.